ACQ2 by Acquired
Building tech and product for marketplaces (with Rover cofounder Phil Kimmey)
13 Jun 2019
“There’s often a desire to keep adding features because ‘Oh wouldn’t it be cool if we could do this or that?’ The reality is if a customer is only spending five minutes with your product, they’re only going to interact with a very tiny subset of your feature set. And so, you’re better off usually improving something that 80% of [customers] interact with that is really core than things around the edges that are more functionality.” - Phil Kimmey We are very excited to be joined by Phil Kimmey, one of the co-founders of Rover (and a frequent member of various 30 under 30 lists), who designed Rover in its infant stages at a Startup Weekend! In this episode, we dive into Rover’s initial design, how the business model was proved, and wrap up with a lengthy discussion on Value-Add Features vs Data-Driven Features. Phil also provides his opinion on what makes new tech and development teams successful and explains why PayPal still sends Rover’s monthly summary statements to his parent’s house. Sponsors:Koyfin: https://bit.ly/acquiredkoyfinBe sure to follow the Acquired Podcast:Follow Acquired: @AcquiredFM, acquired.fmLinks from the Show:Conjoined Triangles of Success
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare